The Senate effectively killed a bid to allow consumers to buy their prescription medicines abroad Monday, requiring U.S. officials to certify the safety and effectiveness of such drugs.

The certification amendment, passed on a 49-40 vote, would require health officials to do something they have long said they cannot.